


The Fund aims to provide a combination of income and long term capital growth.
| Name | % Net Assets |
|---|---|
| HSBC Holdings | 8.8% |
| Royal Dutch Shell | 7.0% |
| BP | 6.8% |
| Glaxosmithkline | 6.8% |
| Travis Perkins | 5.1% |
| Vodafone Group | 4.6% |
| Astrazeneca | 4.3% |
| UNILEVER | 4.1% |
| SIGNET JEWELERS LTD | 3.8% |
| British American Tobacco | 2.9% |
| Key | % Net Assets |
|---|---|
| 8.8% | |
| 7.0% | |
| 6.8% | |
| 6.8% | |
| 70.6% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 2,574.93p |
| Currency | GBP |
| Change | -3.98p |
| % | -0.15% |
| YTD change | 460.66p |
| YTD % | 21.79% |
| Fund Inception | 02/10/1978 |
|---|---|
| Fund Manager | Alastair Mundy |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £10000000 |
| Additional | £100 |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 4.50% |
| Annual Mang't | 1.00% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.17 |
You are here: research